Home › Funds › DEERFIELD MANAGEMENT COMPANY, L.P. › PHVS

DEERFIELD MANAGEMENT COMPANY, L.P. position in PHVS

PHARVARIS N V · Health Care

DEERFIELD MANAGEMENT COMPANY, L.P. reported holding 3,376,042 shares of PHVS (PHARVARIS N V) in its Q2 2026 13F filing — a position valued at US$116.7M, representing 1.46% of its reported portfolio and ranking #17 among its reported holdings. DEERFIELD MANAGEMENT COMPANY, L.P. has disclosed PHVS holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

Latest position (Q2 2026)3.38M sh
Reported value held$116.74M
Portfolio Weight1.46%
First reportedQ4 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How DEERFIELD MANAGEMENT COMPANY, L.P.'s PHVS position evolved

DEERFIELD MANAGEMENT COMPANY, L.P. first disclosed a stake in PHVS in Q4 2023 at 812,236 shares (US$22.8M). The position peaked in Q2 2026 at 3,376,042 shares, worth US$116.7M. Across 11 filings, DEERFIELD MANAGEMENT COMPANY, L.P. increased the stake 6 time(s), trimmed it 1 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 3,376,042 shares valued at US$116.7M — an increase of 250,000 shares quarter over quarter.. Notable position changes include a 31% increase in Q1 2024, a 32% increase in Q2 2024 (shares rose 2% over the following quarter), a 45% increase in Q3 2024.

Quarter by quarter

QuarterSharesValueChange
Q4 2023 812.24K $22.78M New
Q1 2024 1.06M $24.53M Add
Q2 2024 1.40M $26.27M Add
Q3 2024 2.03M $37.63M Add
Q4 2024 2.02M $38.67M Reduce
Q1 2025 2.02M $31.67M Hold
Q2 2025 2.02M $35.51M Hold
Q3 2025 2.44M $60.94M Add
Q4 2025 3.13M $86.75M Add
Q1 2026 3.13M $88.31M Hold
Q2 2026 3.38M $116.74M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PHVS and 13F data

PHVS (PHARVARIS N V) is a Health Care company. 49 other funds we track also report a position in PHVS — the largest reported positions include GENERAL ATLANTIC, L.P. (US$226.5M), Foresite Capital Management IV, LLC (US$165.2M), venBio Partners LLC (US$160.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PHVS

All PHVS fund holders →

FAQ

How long has DEERFIELD MANAGEMENT COMPANY, L.P. held PHVS?

DEERFIELD MANAGEMENT COMPANY, L.P. has disclosed PHVS holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

What is DEERFIELD MANAGEMENT COMPANY, L.P.'s current position in PHVS?

As of Q2 2026, DEERFIELD MANAGEMENT COMPANY, L.P. holds 3.38M shares of PHVS (PHARVARIS N V), valued at $116.74M, representing 1.46% of its reported portfolio and ranking #17.

Has DEERFIELD MANAGEMENT COMPANY, L.P. been buying or selling PHVS?

In the latest 13F filing (Q2 2026), DEERFIELD MANAGEMENT COMPANY, L.P. increased its position in PHVS. The position peaked in Q2 2026 at 3.38M shares.

Which other funds hold PHVS?

Other major institutional holders of PHVS include GENERAL ATLANTIC, L.P., Foresite Capital Management IV, LLC, venBio Partners LLC, among 49 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.